Skip to content

Category: Science Medical

Launch of Evinco Therapeutics: A pioneering biotech company advancing immune therapies for Alzheimer’s disease

By API User

  Evinco Therapeutics is an Australian start-up on a mission to transform the treatment of Alzheimer’s disease and other neuroinflammatory conditions Melbourne, Australia, 4 December 2025 – An exciting chapter in medical innovation begins today with the official launch of Evinco Therapeutics Pty Ltd (“Evinco” or “Company”), a Melbourne-based biotechnology company developing advanced immune-based therapies … Continued

Monash advancing medical breakthroughs with Victoria’s most advanced MRI scanner

By API User

Monash University will today launch Victoria’s most advanced, research-dedicated MRI scanner to support world-class researchers as they accelerate breakthroughs in critical health challenges like dementia, schizophrenia, addiction, epilepsy and cancer.  The cutting-edge Siemens Healthineers MAGNETOM Cima.X 3T MRI scanner, housed at Monash Biomedical Imaging (MBI) in Clayton, utilises multimodal imaging capabilities to deliver scans quicker … Continued

NSW Government urged to develop rare disease strategy

By API User

  A new report by the McKell Institute has found a rare disease strategy is urgently needed in NSW as more than 600,000 people continue to face fragmented and inconsistent care.   The report, A Rare Kind of Care, found that while rare diseases are individually uncommon they still affect up to 8% of the population, … Continued

4DMedical secures US$10m CTVQ orders in Philips deal

By API User

Highlights• Philips will add CT:VQ™ to its North American product catalogue, backed by minimum contractual order commitment of approximately A$15m (US$10m) over two years • CT:VQ™ sales via Philips will be on full commercial terms • Philips to deploy dedicated sales and clinical specialists with CT:VQ™ targets across United States and Canada • Commercial launch … Continued

Nexsen Appoints Global Clinical Leader, Professor Shekhar Kumta, to Board

By API User

3 December 2025 – Perth, Australia | Nexsen Limited (ASX:NXN) has today announced the appointment of internationally recognised surgeon-scientist, Professor Shekhar Kumta, as a Non-Executive Director. Professor Kumta brings more than 45 years’ experience across Australia and Hong Kong, with senior faculty, hospital governance and medical leadership roles spanning major institutions including the Chinese University … Continued

International Day of People with Disability: Longer consults and more home visits are needed for accessible health outcomes

By API User

The Royal Australian College of GPs (RACGP) is calling for the Federal Government to improve support for longer consultations and home visits, in line with the goals of the 2025 International Day of People with Disability.  This year’s theme focuses on “fostering disability inclusive societies for advancing social progress”. The Department of Health, Disability and Ageing also released documentation covering the theme, which suggests a range … Continued

LTR Pharma Secures Ethics Approval for SPONTAN® Phase II Study, Recruitment to Begins Early 2026

By API User

3 December 2025 – Melbourne, Australia | LTR Pharma Limited (ASX:LTP) has today announced it has received Human Research Ethics Committee (HREC) approval from Bellberry (NHMRC-certified) for its SPONTAN® Phase II pharmacokinetic and multiple-dose clinical study, paving the way for recruitment to commence in Q1 calendar year 2026.  The Phase II study has been designed … Continued

Zapping stem cells could boost growth of new tissues and organs

By API User

Scientists in Melbourne have discovered how tiny electrical pulses can steer stem cells as they grow, opening the door to new improved ways of creating new tissues, organs, nerves and bones. Dr Amy Gelmi, a Senior Lecturer at RMIT University’s School of Science, led the work using advanced atomic force microscopy to track how stem … Continued